Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Markets across are going bananas over apparent Gilead's remdesivir solution to the Covid-19. Are there any implications for us?
How's the short doing, Captain?
That cracked me up. Keep it on, dude, until debt-collectors knock on your paper box:)
Piper, what about the 3 race for the vaccine/treatment?
Last weekend I spent answering what seemed like genuine concerns of investor crowd. Guess what - it is Saturday and exactly the same questions start appearing again about WHO comments etc. Guys, you only have yourselves to blame - you had a whole week to build a position here. Especially with Mologic tie-up news being thrown for free here with no reaction to the sp for most of the week. Now, you got greedy or sold too soon and now make desperate and pathetic attempts to get in back for a penny less. I really hope that there are transformational news on Monday just to know there will be hundreds of smart Alecs who have lost big time by trying to make a few hundred on trading.
Bought these bad boys in two tranches today. I think the reality of physical oil trade is now a bit different from what we see in the oil futures markets. Do we know which mark of oil characteristics does CASP oil have? Is it Urals?
I see that from 20 April, Kazakhstan has started relaxing its quarantine restrictions which should gradually restore the vehicular movements and petrol demand. I also note the bullish day for many oilers today which should have some effect here as well.
Very interesting angle from Trump's conference.
He said that AB test can be used to identify whether plasma can be taken for treatment. So, there are so many practical usages of this test.
alwayswinning, from the RNS
"Omega will also CE Mark the test under the MTA, after which both parties will work together to commercialise the test."
Commercialise...
Ken - please do not regard this as ramping and DYOR - I am in ODX.
Hi Ken,
Yes, I do hold one Covid play stock at the moment and am in blue. I have done fantastically well with KAZ on its way down and the rebound, as I have reported, and plan to do so again. But I think this rise was too much too soon and not justified at present. I may be wrong, but I think at these levels and at the present time, KAZ is not an attractive purchase.
Good analogy, Disco.
And I think some are beginning to realise it already. Abysmal state of the oil futures, airlines on the brink of collapse, retail, travel, hotel sectors on life support machines. Yes, China is back to work (they say) but who are they going to sell their product to? The picture painted by the Dow levels is that we had a minor hiccup, a healthy correction and a profit-taking. As I said, in 2009 Dow would be at 15,000. Kaz is indeed holding remarkably well, but I have learnt with this company not to read too much into that - for 3 days it is holding remarkably well, then for 3 days it will be going down 15% when RIO and others will be 7% down. I am awaiting a significant re-rating down, if not then good luck to all holders, I will be wrong but I will be putting my money elsewhere.
Why would Wednesday be good?
It is hard to be interested at these prices to be honest. Yes, you can day trade perhaps and Dow keeps on saving this from falling but it can't last forever.
No way, you think they are that dumb not to be aware for the whole day of the "solution"? If that was of any relevance, he could surely say now we have come up with the solution, we just need to verify and check it. You understand how important that would be for the Govt under fire they are not doing enough. I don't buy it. There is another explanation.
Yes, and on Saturday the Govt said they are still working on the test and they don't have a perfect test yet...
https://www.telegraph.co.uk/global-health/science-and-disease/coronavirus-news-uk-latest-cases-deaths-lockdown-vaccine-update/
5:09pm
Professor Powis: 'We don't have the perfect test for antibodies yet'
A member of the media references previous modelling by Sir Patrick Vallance suggesting there could be 15 million people in the UK infected by the virus.
Prof Powis says the UK is working on an antibody test to asses the real number of infections in the commuity.
He says: "What's important now as we are a few weeks further on is actually getting the real number on infections in the community and that is best done by testing antibodies i.e. testing people who have caught the virus, and then developed an immune response and then have antibodies in their blood.
"We are beginning to see some studies from other countries that are doing that, it's not straightforward, firstly because the tests are still being worked out and we don't have the perfect test for antibodies yet.
"We don't know how many people produce antibodies when they have the virus and when they produce it and how long they last for. That's the important information that will give us an actual figure that is much more closer to the number of infections.
"That work is ongoing in the UK at the moment so we can have that information in the UK rather than relying on other countries.
Trek - I always respect contrarian views, never dismiss any argument.
But you have been asking for a link, people kindly gave you the link. Now you are asking about cash, and so on and so on. Even I begin to think about some ulterior motives on your part. Mrs Trek must be a saint:)
Sieveco - agree with most of your statements, except this:-
"IF ODX produces a reliable antibody test and IF in the meantime evidence of immunity emerges (through it turning out that people are only getting Covid-19 once) then ODX will do very very well imo. If not, then it won't."
I think ODX will do very well if just your first "IF" works out. The US and UK Govts have said they will be using this test fully realising and understanding it might not be a guarantee of immunity, there are plenty of other usages for this test. A very important distinction, IMHO.
Trek - but I don't present myself as a trader who crosses all the T's and puts dots over all i's. You are. And yet a "not so unreasonable assumption" here and a "probability" there. I am satisfied that their collaboration is funded for by the Government, I just cannot see how it could be otherwise. Again, of course please DYOR and don't take anything I say for granted. But you have posted numerous posts on here and in some of them basically assume they are in dire need of cash to continue with the AB test work, which there is no evidence of.
Trek - you also make unsupported assumptions.
"they have a £2m credit line and are probably 50% into it by now"
What made you think that? Have there been any statements by the company supporting any view they might be running out of cash? Just because it is good to raise when the sp is up, does not mean they have to.
I would be surprised if the joint research they are doing is not funded by the Government, as what would be the point of doing it for a commercial enterprise?
Thinking about what value to ascribe to the company.
I have seen people ascribing between 15 and 25p to the existing projects. Let's take it 20p. So are you telling me the value of the possibility of being at the front of developing and manufacturing the essential test for the returning the society back to the normal functionality is worth measly 9p? I think, we are lucky the institutions are offloading and some people can still join the train as otherwise this would have shot into the stratosphere already.
Kopfkissen - how could you have invested relying on "total immunity" basis if it was said throughout, from, basically, January 2020 onwards, that persons who had Covid-19, can have it again. There is nothing new in these reports, and it was said throughout. The antibody test will have a lot of usage, but no-one should have thought it was a silver-bullet.